Market revenue in 2024 | USD 883.4 million |
Market revenue in 2030 | USD 940.5 million |
Growth rate | 1.6% (CAGR from 2025 to 2030) |
Largest segment | Antivirals |
Fastest growing segment | Antibacterials |
Historical data | 2018 - 2023 |
Base year | 2024 |
Forecast period | 2025 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Antibacterials, Antivirals, Antifungals |
Key market players worldwide | Pfizer Inc, Abbott Laboratories, Gilead Sciences Inc, Bristol-Myers Squibb Co, Merck & Co Inc, Sandoz Group AG ADR, B. Braun, Novo Holdings, Mankind Pharma, Bayer AG, AstraZeneca PLC, Boehringer Ingelheim Pharma |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to anti-infective agents market will help companies and investors design strategic landscapes.
Antivirals was the largest segment with a revenue share of 57.98% in 2024. Horizon Databook has segmented the Argentina anti-infective agents market based on antibacterials, antivirals, antifungals covering the revenue growth of each sub-segment from 2018 to 2030.
In 2021, the Drugs for Neglected Diseases initiative (DNDi) launched a Phase III clinical trial in Argentina aimed at validating a two-week treatment regimen with benznidazole for adults in the chronic phase of Chagas disease. Benznidazole is currently the standard treatment for this disease and has proven effective in combating the infection.
Additionally, the presence of infectious diseases such as HIV is influencing the market landscape. According to UNAIDS, it is estimated that in 2023, approximately 140,000 individuals are living with HIV in Argentina, with the actual number likely ranging between 130,000 and 150,000. The HIV prevalence rate among men aged 15 to 49 stands at 0.5%, with a range of 0.4% to 0.6%.
Horizon Databook provides a detailed overview of country-level data and insights on the Argentina anti-infective agents market , including forecasts for subscribers. This country databook contains high-level insights into Argentina anti-infective agents market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
No related regions found.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account